GP6 and hyperinsulinemic hypoglycemia, familial, 4: Due to this important pharmacological research directions for treating hemostatic deficiencies are concerning the development of new drugs targeting, among others, the PAR1 thrombin receptor or GP VI platelet-specific collagen receptor25.